Ingenus was born in 2010, came to market in 2012 and we are continuously expanding our roster of high impact generic pharmaceutical products. We’ve built Ingenus on a foundation of innovation and collaboration to meet the unique needs of U.S. consumers. Our expansive generic product focus proves it.
With our team of over 140 developers and scientists, Ingenus today is poised to file 15- 25 ANDAs per year.
